Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 23, 2019
Pharmacy Choice - News - Over-the-Counter Drugs - March 23, 2019

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 164     Next >>     Go To Page:

12/31/18 - Innovus Pharmaceuticals Announces $3.17 Million Private Placement
Innovus Pharmaceuticals an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women s health and respiratory diseases, today announced that it has entered into a definitive agreement with a healthcare-dedicated institutional...
12/29/18 - Sen. Grassley Marks Policy, Oversight Accomplishments of the 115th Congress
Charles E. Grassley, R- Iowa, issued the following news release:. Chuck Grassley of Iowa marked a series of policy and oversight accomplishments in the 115th Congress. "Serving the people of Iowa as their United States Senator is my first priority and it's an honor that I take seriously," Grassley said.
12/28/18 - Bristol-Myers Squibb Announces Offer from Taisho Pharmaceutical Holdings Co., Ltd to Purchase UPSA
By a News Reporter-Staff News Editor at Pharma Business Week Bristol-Myers Squibb Company announced that Taisho Pharmaceutical Holdings Co., Ltd. has offered to purchase Bristol-Myers Squibb's UPSA consumer health business for $1.6 billion. "The announcement marks the culmination of an in-depth strategic review to identify the best option to gro
12/28/18 - Nutraceutical Supplements Market: Emerging Economies Expected to Influence Growth Until 2027: With the evolving definition of health and wellness, an increasing preference of specialty ingredients is gaining center stage in the nutraceutical ingredie
Rockville Pike, MD 12/28/2018 The nutraceutical supplements market is projected to account for over US$ 80,700 million in 2019, according to a new Fact.MR study. Overall growth of the nutraceutical supplements market can be attributed to,. Increasing adoption of nutraceutical supplements as pharmaceutical alternatives Increasing healthcare co
12/28/18 - Purchase of Non-Prescription Drugs (Materials, Science and Medicine)
Address: Tel: +66-0 5393 900. Description: Tenders are invited for Purchase of Non-Prescription Drugs (Materials, Science and Medicine. Chemical analysis of blood in patients (41.11. 60. 0) Number 20.
12/28/18 - Sen. Chuck Grassley (R-IA) News Release
Chuck Grassley of Iowa marked a series of policy and oversight accomplishments in the 115th Congress. "Serving the people of Iowa as their United States Senator is my first priority and it's an honor that I take seriously," Grassley said. "As chairman of the Senate Judiciary Committee and through my extensive oversight efforts, my work focuses on
12/27/18 - HEALTH & SUPPORT
Monday evenings at 63 Jefferson Ave., Salem; and from noon to 1:30 p.m. Fridays at 75 Lindall St., Danvers. The Beverly and Addison Gilbert Hospital's Speakers Bureau is a free service designed to bring timely information on a variety of health-related topics. Held 7-8: 30 p.m. on the last Wednesday of each month in the doctors' conference room at
12/26/18 - Approaches for reducing reflux disease
It seems like almost everyone has been diagnosed with gastroesophageal reflux disease. I exaggerate, of course, but the pharmaceutical companies do an excellent job of making it appear that way with advertising. GERD affects as much as 40 percent of the U.S. population.
12/26/18 - Russ Daly: Antibiotic use in livestock is down ? how about on your farm?
Every year, the Food and Drug Administration publishes a report on the sales of antibiotics for use in food animals. It's an interesting "big picture" view of what livestock producers use to keep their animals healthy and productive. That's because on January 1, 2017, new regulations went into effect governing how livestock producers could obtain a
12/25/18 - REPEAT - International Cannabis Increases European Distribution Footprint by Over 1,300 Pharmacies [Sport360]
-ICC International Cannabis Corp. is pleased to announce that its exclusive European distribution partner, Cosmos Holdings, Inc., has acquired Greek pharmaceutical wholesaler, Cosmofarm Ltd.. Established in 1994, Athens based Cosmofarm provides a comprehensive range of pharmaceutical products to over 1,130 pharmacies. Cosmofarm has been authorized.
12/24/18 - International Cannabis Increases European Distribution Footprint by Over 1,300 Pharmacies
ICC International Cannabis Corp. is pleased to announce that its exclusive European distribution partner, Cosmos Holdings, Inc., has acquired Greek pharmaceutical wholesaler, Cosmofarm Ltd... Cosmofarm has been authorized and endorsed by Greece s National Organization for Medicines under Good Distribution Practices to distribute over-the-count
12/24/18 - REPEAT - International Cannabis Increases European Distribution Footprint by Over 1,300 Pharmacies
ICC International Cannabis Corp. is pleased to announce that its exclusive European distribution partner, Cosmos Holdings, Inc., has acquired Greek pharmaceutical wholesaler, Cosmofarm Ltd... Cosmofarm has been authorized and endorsed by Greece s National Organization for Medicines under Good Distribution Practices to distribute over-the-count
2/21/19 - Dietary supplements to get more federal scrutiny
Supplements, which are regulated by the Food and Drug Administration, will now be subject to new enforcement strategies, including a new rapid-response tool that can alert consumers to unsafe products, the FDA said in a written statement. The move is one of the most significant modernizations of dietary supplement regulation and oversight
2/21/19 - FDA advances new proposed regulation to make sure that sunscreens are safe and effective
The U.S. Food and Drug Administration today issued a proposed rule that would update regulatory requirements for most sunscreen products in the United States. This significant action is aimed at bringing nonprescription, over-the-counter sunscreens that are marketed without FDA- approved applications up to date with the latest science to better ens
2/21/19 - Innovus Pharma Announces Regulatory Filings by its International Distribution Partner, Lavasta Pharma, for ProstaGorx in Certain Gulf Countries
Innovus Pharmaceuticals, Inc., an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men s and women s health and vitality and respiratory diseases, announced today the...
2/21/19 - Prescription Antiacne Drugs Market Trends, Analysis and Forecast 2016 2023
Albany, NY 02/20/2019 Prescription Antiacne Drugs Market. Acne is a common disorder that leads to formation of lesions or zits. The disease is characterized by overproduction of sebum due to high level of production of male hormone named as androgen during puberty.
2/21/19 - Senate Health Committee Issues Testimony From University of Maryland School of Pharmacy
The Senate Health, Education, Labor and Pensions Committee issued the following testimony by drew Coop, professor of pharmaceutical sciences in the University of Maryland School of Pharmacy, at a hearing to examine managing pain during the opioid crisis:. Andrew Coop and I am a Professor of Pharmaceutical Sciences in the University of Maryland's Sc
2/20/19 - ACETO CORP - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
On February 19, 2019, the Debtors filed the Chapter 11 Cases in the Bankruptcy Court. The Debtors have proposed to jointly administer the Chapter 11 Cases under the caption In re Aceto Corporation, et al. For a description of the Chapter 11 Cases and related matters, including the DIP Credit Agreement and the Asset Purchase Agreement, please see It
2/20/19 - Alvogen Launches Generic Equivalent to Suboxone? (buprenorphine/naloxone) Sublingual Film
Alvogen, has launched its generic equivalent to Suboxone sublingual film in the U.S., which will be available in 2 mg/0. 5 mg, 4 mg/1mg, 8 mg/2mg, and 12 mg/3mg strengths. The launch took place, pursuant to a 31 January 2019 agreement between Alvogen and Indivior, following the issuance of a mandate from the U.S. Court of Appeals for the Federal
2/20/19 - Alvogen Launches Generic Equivalent to Suboxone (Buprenorphine/Naloxone) Sublingual Film
Global pharmaceutical company, Alvogen, has launched its generic equivalent to Suboxone sublingual film in the U.S., which will be available in 2 mg/0. 5 mg, 4 mg/1mg, 8 mg/2mg, and 12 mg/3mg strengths.. The launch took place, pursuant to a 31 January 2019 agreement between Alvogen and Indivior, following the issuance of a mandate from the U.S
2/20/19 - Bausch Health Acquires Eton Pharmaceuticals' EM-100 Investigational Eye Drop for the Treatment of Itchy Eyes Associated With Allergies
LAVAL- Bausch Health Companies Inc. and Bausch+ Lomb, its wholly owned subsidiary and a leading global eye health company, and Eton Pharmaceuticals, Inc. today announced a subsidiary of Bausch Health has acquired the U.S. rights to Eton Pharmaceuticals' EM-100, an investigational eye drop that, if approved, will be the first over-the-counter preser
2/20/19 - BAUSCH HEALTH COMPANIES INC. - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations
All currency amounts are expressed in U.S. dollars, unless otherwise noted. Our portfolio of products falls into four operating and reportable segments: Bausch+ Lomb/International, Salix, Ortho Dermatologics and Diversified Products.? The Bausch+ Lomb/International segment consists of: sales in the U.S.. ?The Salix segment consists of sales in
2/20/19 - Call for Separate Regulations for Medical Devices and OTC Drugs
The 4th International Conference on Phar maceuticals and Medical Devices which concluded on the 19th of February witnessed the participation of drug regulators from over 30 countries including Russia, Kenya, the UK, Malaysia, Indonesia, Saudi Arabia and Uzbekistan, along with participation of Indian drug regulators from 15 states. The conference wa
2/20/19 - JOHNSON & JOHNSON - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION
Organization and Business Segments Description of the Company and Business Segments Johnson& Johnson and its subsidiaries have approximately 135,100 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The Company conducts business in virtually all countries of the.
2/20/19 - Tapentadol Market - Highlight Health Threat Factors 2025: The growing prevalence of chronic diseases is leading to the high occurrence of chronic musculoskeletal pain, which is likely to create an upswing in the demand for tapentadol worldwide.
San Francisco, CA 02/20/2019 Global Tapentadol Market: Snapshot. The growing prevalence of chronic diseases is leading to the high occurrence of chronic musculoskeletal pain, which is likely to create an upswing in the demand for tapentadol worldwide. Tapentadol is also used for the treatment of moderate to severe acute pain.
Articles(s): 1 - 25 of 164     Next >>     Go To Page:


© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415